Software surveillance company VigiLanz rolls out clinical trial enrollment tool

VigiLanz, which specializes in clinical software surveillance, debuted its latest tool to identify a greater number of eligible candidates for clinical trial enrollment. The company’s VigiLanz Research automates the patient identification process in near real time, which helps speed the process for sites and hit time-sensitive enrollment targets, the company said in an Oct. 11 release.